Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate
About this item
Full title
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate
Author / Creator
Publisher
Germany
Journal title
European journal of nuclear medicine and molecular imaging, 2016-09, Vol.43 (10), p.1802
Language
English
Formats
Publication information
Publisher
Germany
Subjects
More information
Scope and Contents
Contents
After peptide receptor radionuclide therapy (PRRT), renal toxicity may occur, particular in PRRT with (90)Y-labelled somatostatin analogues. Risk factors have been identified for increased probability of developing renal toxicity after PRRT, including hypertension, diabetes and age. We investigated the renal function over time, the incidence of nep...
Alternative Titles
Full title
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_27160225
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_27160225
Other Identifiers
E-ISSN
1619-7089
DOI
10.1007/s00259-016-3382-9
